Congress moves to break up insurer-provider mergers, forcing divestitures by 2026
H.R. 5433 — POP Act · Filed by Valerie Hoyle (D-OR) · 5 cosponsors · Introduced Sep 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits any company from simultaneously owning both a health insurance company and certain healthcare providers (doctors, clinics, etc.) that bill Medicare. Companies currently in violation have 2 years to divest one or the other; future acquisitions have 1 year. The bill empowers the FTC, DOJ, state attorneys general, and HHS to enforce the rule through lawsuits, requiring divestment and disgorgement of profits earned during the violation. Medicare Advantage and Part D plans are barred from contracting with organizations that violate the rule starting in 2026.
Why we flagged it
The bill's core mechanism is a structural prohibition on vertical integration between insurers and providers—a classic antitrust remedy designed to eliminate conflicts of interest in healthcare markets. It is not a price control, subsidy, or regulatory carve-out, but rather a forced separation of competing economic interests.
What the text implies
- Divestment may reduce operational synergies and increase administrative costs for affected entities, potentially raising premiums or reducing provider network efficiency in the short term.
- The rule applies only to Medicare-billing providers, leaving commercial insurance-provider integration untouched, creating a two-tier market where non-Medicare patients may still face steering incentives.
- Disgorgement of profits into an FTC-administered community health fund creates a new federal spending mechanism outside the normal appropriations process, with unclear governance and distribution criteria.
- Management services organizations (MSOs) are swept into the prohibition even if they do not directly own providers, potentially disrupting legitimate administrative outsourcing arrangements.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill removes financial incentives for insurers to steer patients toward affiliated providers or deny care to boost insurer profits, potentially lowering costs and improving care quality for Medicare beneficiaries. However, enforcement depends on regulatory capacity and the rule may reduce some operational efficiencies, creating a mixed but net-positive outcome for ordinary people.
Who stands to gain
- Medicare beneficiaries (lower costs, reduced steering)
- Independent healthcare providers (reduced competition from integrated insurers)
- State attorneys general (enforcement authority and potential settlement revenue)
Named in the bill
Federal Trade Commission (FTC), Department of Justice Antitrust Division, HHS Office of Inspector General, State attorneys general, Medicare Advantage organizations, Medicare Part D plans, Health insurance issuers, Applicable providers (physicians, clinics, outpatient facilities), Management services organizations
Where it stands
5 cosponsors: 5 Democrats.
- Sep 17, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 17, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $3,590,000 in lobbying spend. A filing names 20 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Valerie Hoyle, the sponsor, reported $639,524 in PAC receipts in the 2026 cycle.
- CVS Health (and Subsidiaries) — $3,570,000 on 1 filing
- Center for Health and Democracy — $20,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (8,848 characters) on Aug 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress moves to break up insurer-provider mergers, forcing divestitures by 2026” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5433 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.